Impact of obesity on hypertension-induced cardiac remodeling: Role of oxidative stress and its modulation by gemfibrozil treatment in rats

Free Radical Biology and Medicine

Volumn 50, Issue 2, 2011, Pages 363-370

  Singh, Randhir ^a   Singh, Amrit Pal ^a,b   Singh, Manjeet ^a   Krishan, Pawan ^a  

^a PUNJABI UNIVERSITY   (India)

^b GURU NANAK DEV UNIVERSITY   (India)

Author keywords

Cardiac fibrosis; Cardiac hypertrophy; Free radicals; Gemfibrozil; Obesity; Oxidative stress

Indexed keywords

COLLAGEN; GEMFIBROZIL; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERTENSION; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; CARDIOMEGALY; DIETARY FATS; GEMFIBROZIL; GLUTATHIONE; HEART VENTRICLES; HYPERTENSION; HYPOLIPIDEMIC AGENTS; MALE; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS; RATTUS NORVEGICUS;

EID: 78651256133     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.11.020     Document Type: Article

References (40)

1. P. Balakumar, A.P. Singh, and M. Singh Rodent models of heart failure J. Pharmacol. Toxicol. Methods 56 2007 1 10
2. A. Rohini, N. Agrawal, C.N. Koyani, and R. Singh Molecular targets and regulators of cardiac hypertrophy Pharmacol. Res. 61 2010 269 280
3. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J. Am. Coll. Cardiol. 53 2009 1925 1932
4. R.S. Vasan Cardiac function and obesity Heart 89 2003 1127 1129
5. C.M. Pawloski, N.L. Kanagy, L.H. Mortensen, and G.D. Fink Obese Zucker rats are normotensive on normal and increased sodium intake Hypertension 19 1992 190 195
6. C. Christoffersen, E. Bollano, M.L. Lindegaard, E.D. Bartels, J.P. Goetze, C.B. Andersen, and L.B. Nielsen Cardiac lipid accumulation associated with diastolic dysfunction in obese mice Endocrinology 144 2003 3483 3490
7. P.M. Barger, J.M. Brandt, T.C. Leone, C.J. Weinheimer, and D.P. Kelly Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth J. Clin. Invest. 105 2000 1723 1730
8. B.N. Finck, and D.P. Kelly Peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart J. Mol. Cell. Cardiol. 34 2002 1249 1257
9. Rose M., Balakumar P., and Singh M. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats Pharmacology 80 2007 177 184
10. N.K. Lebrasseur, T.A. Duhaney, D.S. De Silva, L. Cui, P.C. Ip, L. Joseph, and F. Sam Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension Hypertension 50 2007 489 496
11. G.A. Bray Medical consequences of obesity J. Clin. Endocrinol. Metab. 89 2004 2583 2589
12. M. Obayashi, M. Yano, M. Kohno, S. Kobayashi, T. Tanigawa, K. Hironaka, T. Ryouke, and M. Matsuzaki Dose-dependent effect of Ang II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy Am. J. Physiol. 273 1997 H1824 H1831
13. A.P. Singh, M. Singh, and P. Balakumar Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats J. Cardiovasc. Pharmacol. 51 2008 596 604
14. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with folin-phenol reagent J. Biol. Chem. 193 1951 265 275
15. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
16. H.D. Wang, P.J. Pagano, Y. Du, A.J. Cayatte, M.T. Quinn, P. Brecher, and R.A. Cohen Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide Circ. Res. 82 1998 810 818
17. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J. Lab. Clin. Med. 61 1963 882 888
18. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
19. O.H. Majane, L. Vengethasamy, E.F. du Toit, S. Makaula, A.J. Woodiwiss, and G.R. Norton Dietary-induced obesity hastens the progression from concentric cardiac hypertrophy to pump dysfunction in spontaneously hypertensive rats Hypertension 54 2009 1376 1383
20. E.F. du Toit, M. Nabben, and A. Lochner A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury Basic Res. Cardiol. 100 2005 346 354
21. H. Poudyal, F. Campbell, and L. Brown Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats J. Nutr. 140 2010 946 953
22. P. Balakumar, M. Rose, and M. Singh PPAR ligands: are they potential agents for cardiovascular disorders? Pharmacology 80 2007 1 10
23. R.M. Touyz, and E.L. Schiffrin Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications Vasc. Pharmacol. 45 2006 19 28
24. J. Yan, M.E. Young, L. Cui, G.D. Lopaschuk, R. Liao, and R. Tian Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity Circulation 119 2009 2818 2828
25. M.E. Young, S. Patil, J. Ying, C. Depre, H.S. Ahuja, G.L. Shipley, S.M. Stepkowski, P.J. Davies, and H. Taegtmeyer Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart FASEB J. 15 2001 833 845
26. A.K. Zaman, S. Fujii, D. Goto, T. Furumoto, T. Mishima, Y. Nakai, J. Dong, S. Imagawa, B.E. Sobel, and A. Kitabatake Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity J. Mol. Cell. Cardiol. 37 2004 525 535
27. N. Shiota, J. Rysä, P.T. Kovanen, H. Ruskoaho, J.O. Kokkonen, and K.A. Lindstedt A role for cardiac mast cells in the pathogenesis of hypertensive heart disease J. Hypertens. 21 2003 1935 1944
28. Y.Y. Li, Y.Q. Feng, T. Kadokami, C.F. McTiernan, R. Draviam, S.C. Watkins, and A.M. Feldman Myocardial extracellular matrix remodeling in transgenic mice over expressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy Proc. Natl. Acad. Sci. USA 97 2000 12746 12751
29. S.J. Watkins, L. Jonker, and H.M. Arthur A direct interaction between TGF beta activated kinase 1 and the TGF beta type II receptor: implications for TGF beta signalling and cardiac hypertrophy Cardiovasc. Res. 69 2006 432 439
30. S. Engeli, P. Schling, K. Gorzelniak, M. Boschmann, J. Janke, G. Ailhaud, M. Teboul, F. Massiéra, and A.M. Sharma The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int. J. Biochem. Cell Biol. 35 2003 807 825
31. J.L. Evans, I.D. Goldfine, B.A. Maddux, and G.M. Grodsky Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr. Rev. 23 2002 599 622
32. S. Serpillon, B.C. Floyd, R.S. Gupte, S. George, M. Kozicky, V. Neito, F. Recchia, W. Stanley, M.S. Wolin, and S.A. Gupte Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction: the role of glucose-6-phosphate dehydrogenase-derived NADPH Am. J. Physiol. Heart Circ. Physiol. 297 2009 H153 H162
33. R. Luan, S. Liu, T. Yin, W.B. Lau, Q. Wang, W. Guo, H. Wang, and L. Tao High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation Cardiovasc. Res. 83 2009 294 302
34. + exchange in neonatal rat cardiac myocytes Circ. Res. 82 1998 1053 1062
35. A. Sabri, H.H. Hughie, and P.A. Lucchesi Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes Antioxid. Redox Signaling 5 2003 731 740
36. R. Aikawa, T. Nagai, M. Tanaka, Y. Zou, T. Ishihara, H. Takano, H. Hasegawa, H. Akazawa, M. Mizukami, R. Nagai, and I. Komuro Reactive oxygen species in mechanical stress-induced cardiac hypertrophy Biochem. Biophys. Res. Commun. 289 2001 901 907
37. W. Zhao, T. Zhao, Y. Chen, R.A. Ahokas, and Y. Sun Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats Mol. Cell. Biochem. 317 2008 43 50
38. A. Guellich, T. Damy, Y. Lecarpentier, M. Conti, V. Claes, J.L. Samuel, J. Quillard, J.L. Hébert, T. Pineau, and C. Coirault Role of oxidative stress in cardiac dysfunction of PPARalpha-/- mice Am. J. Physiol. Heart Circ. Physiol. 293 2007 H93 H102
39. G. Wang, X. Liu, Q. Guo, and S. Namura Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels Brain Res. 1359 2010 247 255
40. A.C. Calkin, M.E. Cooper, K.A. Jandeleit-Dahm, and T.J. Allen Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation Diabetologia 49 2006 766 774